26 pages | 8 1/2 x 11
The FDA requested that the IOM examine the ethical and informed consent issues that should be considered when conducting clinical trials to evaluate drug safety. This report outlines when and how the FDA should conduct clinical trials to protect the public's health and the health of trial participants.
National Research Council. Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report. Washington, DC: The National Academies Press, 2010.
Please select a format: